Skip to main content
The Journal of Nutrition logoLink to The Journal of Nutrition
. 2016 Aug 3;146(9):1762–1768. doi: 10.3945/jn.116.233940

Coffee Drinking Is Widespread in the United States, but Usual Intake Varies by Key Demographic and Lifestyle Factors1,2,3

Erikka Loftfield 4,*, Neal D Freedman 4, Kevin W Dodd 5, Emily Vogtmann 4, Qian Xiao 4, Rashmi Sinha 4, Barry I Graubard 4
PMCID: PMC4997286  PMID: 27489008

Abstract

Background: Despite widespread popularity and possible health effects, the prevalence and distribution of coffee consumption in US adults are poorly characterized.

Objective: We sought to estimate usual daily coffee intakes from all coffee-containing beverages, including decaffeinated and regular coffee, among US adults according to demographic, socioeconomic, and health-related factors.

Methods: Dietary intake data from ≤2 nonconsecutive 24-h dietary recalls and a food-frequency questionnaire administered during the NHANES 2003–2006 were used to estimate the person-specific probability of consuming coffee on a particular day and the usual amount consumed on consumption days. Trends in population mean coffee consumption over time were evaluated by using multiple linear regression and 1-d 24-h recall data from NHANES 2003–2012. Analyses were weighted to be representative of the US adult population aged ≥20 y.

Results: An estimated 154 million adults, or 75% of the US population, aged ≥20 y reported drinking coffee; 49% reported drinking coffee daily. Prevalence did not vary by sex, education, income, or self-reported general health (all P ≥ 0.05) but did vary by age, race/ethnicity, smoking status, and alcohol drinking (all P < 0.05). Among coffee drinkers, the mean ± SE usual intake was 14.1 ± 0.5 fluid ounces/d (417 ± 15 mL/d). Mean usual intakes were higher in men than women, in older age groups than in those aged 20 to <30 y, in non-Hispanic whites than in non-Hispanic blacks or Hispanic/other races, in smokers than in never smokers, and in daily alcohol consumers than in nonconsumers (all P < 0.05). Population mean coffee consumption was stable from 2003 to 2012 (P-trend = 0.09).

Conclusions: Coffee is widely consumed in the United States, with usual intakes varying by lifestyle and demographic factors, most notably by age. Longitudinal studies are needed to determine whether observed differences by age reflect birth cohort effects or changes in drinking patterns over the lifetime.

Keywords: coffee, usual intake, population survey, National Cancer Institute method, diet

Introduction

Coffee is thought to have originated from a region in Ethiopia called Kaffa >1000 y ago. Approximately 600 y later, the first coffee shop opened in Constantinople, and by the early 17th-century coffee had spread from the Arabian Peninsula, to India, and then to Europe where it was firmly established as a global commodity (1). In 2015, domestic coffee consumption in the United States reached an estimated 1.4 billion kg/y, making it the second largest coffee market in the world after the European Union (2). The worldwide popularity of coffee combined with the possibility that coffee consumption may positively or negatively affect health has prompted numerous epidemiologic studies. For example, studies have reported both positive and inverse associations of coffee with cardiovascular disease (35), but they have generally reported inverse associations with total mortality (6, 7) as well as with diabetes (8), Parkinson disease (9), depression (10, 11), and certain cancers, including liver (12, 13), colorectal (1416), endometrial (17, 18), melanoma (1921), and nonmelanoma skin cancer (22, 23). In 2015, the Scientific Report of the Dietary Guidelines Advisory Committee concluded that moderate coffee consumption (3–5 cups/d) can be a part of a healthy diet (24). Yet, the prevalence and distribution of US coffee consumption remain poorly characterized.

Diet-health hypotheses are typically concerned with “usual” or long-term average intakes rather than “acute” or 1-d intakes as captured by a single 24-h dietary recall. Thus, describing the distribution of usual coffee intake among US adults is critical to understanding the potential impact of coffee drinking on health. Characterizing whether coffee consumption varies according to key demographic, socioeconomic, and other health-related factors may also inform the design of future studies. Although, to our knowledge, there are currently no peer-reviewed estimates of usual coffee intakes among US adults, the nationally representative 2003–2006 NHANES interview collected multiple nonconsecutive 24-h dietary recalls and an FFQ (25, 26), which can be combined to estimate usual intakes of an episodically consumed food component, such as coffee, by using validated statistical methods (27).

The primary objectives of this article were to estimate the prevalence of coffee consumption and the distribution of the amount of usual coffee consumption among adults in the United States by demographic, lifestyle, and health status groups with the use of the National Cancer Institute (NCI6) method for incorporating data on coffee consumption from 2 d of dietary recall and an FFQ (28). In addition, 24-h dietary recalls collected from 2003 through 2012 by NHANES were used to assess trends in population mean coffee consumption over time. A secondary objective was to evaluate differences in the prevalence and distribution of coffee consumption when using “acute” as compared with “usual” estimates of coffee intake.

Methods

Study design.

Starting in 1999, the NHANES became a continuous annual survey that collects data on the health, nutritional status, and health behaviors of the noninstitutionalized civilian resident population of the United States in a timely manner in order to address emerging public health issues and to provide objective estimates on health-related topics. A complex, multistage, probability sample design is used to select ∼12,000 persons/2-y cycle. Survey participants report demographic, socioeconomic, dietary, and health-related history during a household interview (29). In addition, they participate in a comprehensive health examination at a mobile examination center (MEC). The dietary interview component of NHANES, called What We Eat in America, is conducted by trained interviewers with the use of the USDA automated multi-pass method and can be used to estimate the types and amounts of foods and beverages consumed. To allow for estimates of usual intakes, two 24-h dietary recalls have been administered in each continuous NHANES cycle since 2002. The first 24-h dietary recall is conducted in the MEC, and the second is completed 3–10 d later by telephone. For NHANES 2003–2004 and 2005–2006, all English- or Spanish-speaking participants aged ≥2 y who completed at least one 24-h dietary recall interview were eligible to complete the FFQ component (previously referred to as the NHANES Food Propensity Questionnaire), which queried about frequency of consumption but not portion size and was developed to be used in combination with 24-h recall data to estimate usual food intakes (25). The FFQ component was mailed to eligible participants (n = 12,285), and the response rate was 92%.

The NHANES protocol was developed and reviewed to be in compliance with the Department of Health and Human Services’ Policy for Protection of Human Research Subjects and was approved by the National Center for Health Statistics’ Research Ethics Review Board. Federal laws protect all data (29). Our analyses used the publicly available NHANES data.

Study population.

To maximize sample size and to increase the reliability of usual coffee intake estimates for population subgroups, we used data from NHANES 2003–2004 and 2005–2006. Participants aged ≥20 y who had completed ≥1 reliable 24-h dietary recall (i.e., met the minimum criteria for quality and completeness established by the USDA’s Food Surveys Research Group) and reported frequency of coffee intake in the previous year on the FFQ were included in this analysis (n = 6219; Figure 1). The overall response rates for the household interview and health examination were 79% and 76% in 2003–2004 and 80% and 77% in 2005–2006, respectively. Of those who were examined in the 2003–2004 and 2005–2006 MEC, 92% and 84% completed reliable in-person and telephone-administered 24-h dietary recalls, respectively. Data from 3 additional cycles of NHANES (2007–2008, 2009–2010, and 2011–2012), which had 24-h dietary recall data but lacked FFQ data, were used to assess trends in population mean coffee consumption over time. Participants aged ≥20 y who completed a reliable in-person 24-h dietary recall were included in this analysis (n = 24,950). Similarly, for NHANES cycles 2003–2012, the mean response rates for the household interview and health examination across the 5 cycles were 78% and 75%, respectively. Of those who were examined in the MEC during this 10-y period, 92% completed a reliable in-person 24-h dietary recall.

FIGURE 1.

FIGURE 1

Participant flow chart, NHANES 2003–2006. *Respondents with <10 missing frequency values were assigned an FFQ sample weight.

Statistical analysis.

We estimated the amount of total reported coffee intake from all coffee-containing beverages, including decaffeinated and regular coffee made from ground or instant coffee and coffee mixes [USDA Food and Nutrient Database for Dietary Studies (FNDDS) 5.0 food code numbers 92100000–92193020]. We defined “coffee drinkers” as those who reported drinking coffee in the previous year on the FFQ. A small number of participants (n = 105) reported “none” to the FFQ item “How many cups of coffee, caffeinated or decaffeinated, did you drink?” yet reported drinking coffee on one or more 24-h dietary recall. We classified these participants as coffee drinkers and imputed a frequency value on the basis of the participant’s mean coffee intake from their two 24-h dietary recalls (coffee intake from the first recall was used if a second recall was not completed), as well as their age, sex, and racial/ethnic group according to the hot-deck method (30). The prevalence of coffee consumption is the estimated proportion of coffee drinkers, and the chi-square test of independence was used to evaluate whether the prevalence of coffee consumption differed by subgroups. We defined “acute coffee intakes” among coffee drinkers as the amount of coffee reported in the first day of the 24-h dietary recall and estimated the distribution of acute coffee intake as percentiles of intake per day. We defined “daily coffee drinkers” as coffee drinkers who reported consuming coffee ≥1 time/d in the previous 12 mo according to their FFQ. Among coffee drinkers, the distribution of usual (i.e., long-term average) coffee intake was estimated by using the NCI method, which has been described in detail elsewhere (28), to incorporate 2 d of dietary recall, an FFQ, and demographic data. Unpaired t tests were used to test for differences in mean usual intakes between each subgroup and the referent group for a given characteristic. The P values from these t tests comparing mean usual intakes are approximate because they are based on only the SEs of the means and do not account for the correlation between pairs of means resulting from the cluster sample design of NHANES and the model-based estimation.

In brief, the NCI method uses a 2-part model: the first part modeled the person-specific probability of consuming coffee on a particular day and the second part modeled the person-specific amount of coffee typically consumed on the days that coffee was consumed. This 2-part modeling allows for correlation between the person-specific random effects included in each of the parts of the model (28). The NCI-developed SAS macros, MIXTRAN version 2.1 and DISTRIB version 2.1 (31), were used to generate variable estimates and predicted intakes after covariate adjustment for the frequency of coffee consumption as reported on the FFQ (<1 cup/mo, 1–3 cups/mo, 1 cup/wk, 2–4 cups/wk, 5–6 cups/wk, 1 cup/d, 2–3 cups/d, 4–5 cups/d, or ≥6 cups/d) (26), day of week of the 24-h dietary recall [weekday (Monday–Thursday) or weekend (Friday–Sunday)], sequence of dietary recall (first or second), age group (20 to <30, 30 to <40, 40 to <50, 50 to <60, or ≥60 y), sex, race/ethnicity (non-Hispanic white, non-Hispanic black, or Hispanic or other race), education (less than a high school education or high school graduate), annual household income (<$55,000 or ≥$55,000), smoking status (never, former, or current), alcohol drinking (nondrinker or <14 or ≥14 g ethanol/d; 14 g ethanol = 1 US standard drink), and general health condition (excellent or very good, good, or fair or poor). Indicator variables, specifying whether a categorical covariate value was missing, were used to retain observations in the analyses with missing covariate data. A Monte Carlo method with 100 simulations/individual was used to estimate the distribution of usual coffee intake. The analyses were weighted by FFQ sample weights that were derived from the NHANES 2003–2004 and 2005–2006 sample weights and modified to account for FFQ nonresponse. To take into account the complex stratified hierarchical cluster sample design of the NHANES when estimating SEs, we used balanced repeated replication variance estimation with 32 replicates for the combined 2 cycles of NHANES; this work used the computational resources of the NIH’s High-Performance Computing Biowulf cluster.

To evaluate trends in population mean intakes, we considered coffee intake from the first 24-h dietary recall in relation to the NHANES survey cycle (2003–2004 through 2011–2012). Sample weighted multiple linear regression models were adjusted for age, sex, and race/ethnicity and predicted marginal means for coffee intake were used to estimate adjusted population mean coffee intakes and SEs (32). The predicted margins were calculated by using linear regression models with main effects for the subgroup variables age, sex, and race/ethnicity and an interaction between NHANES survey cycle as a categorical variable and each main effect. By using a Wald F test, P values for heterogeneity of trends between the levels of the subgroup variable of interest and NHANES survey cycle as a continuous variable were computed. All of the analyses were conducted by using SAS (version 9.3; SAS Institute) or SUDAAN (version 11.0; RTI International) software.

Results

Prevalence of coffee consumption.

The estimated proportion of coffee drinkers was 74.7%, representing 154.4 million US adults aged ≥20 y according to data collected during 2003–2006 in a nationally representative sample (Table 1). The prevalence of coffee drinking did not differ by sex or general health condition or by education or household income (all P > 0.05) but differed considerably by age (P < 0.001): 59% of US adults who were between the age of 20 and 30 y were coffee drinkers compared with 86.4% of US adults who were aged ≥60 y. The prevalence of coffee drinking also differed by race/ethnicity (P < 0.001) and smoking status (P < 0.001). More than 75% of non-Hispanic whites and Hispanics/other races were coffee drinkers but only 61.4% of non-Hispanic blacks were coffee drinkers, and >80% of former and current smokers were coffee drinkers but only 67.2% of never smokers were coffee drinkers.

TABLE 1.

Prevalence of coffee drinking among US adults aged ≥20 y, and estimated usual coffee intakes among reported coffee drinkers: NHANES 2003–20061

Sample sizes
Weighted to US adult population
Usual intake,2 fl oz/d
Percentile ± SE
Characteristic Total,3 n Coffee drinkers,4 n Total,5 n (millions) Coffee drinkers,6 n (millions) Coffee drinkers, % P7 Mean ± SE P8 50th 75th 95th
Overall 6219 4730 206.6 154.4 74.7 14.1 ± 0.5 11.4 ± 0.4 19.7 ± 0.6 39.0 ± 1.8
Sex 0.06
 Female 3364 2495 112.5 82.4 73.3 12.6 ± 0.7 Ref 10.2 ± 0.5 17.5 ± 0.8 34.2 ± 2.5
 Male 2855 2235 94.1 72.0 76.5 15.8 ± 0.8 <0.001 12.9 ± 0.7 22.0 ± 1.0 42.9 ± 3.3
Age <0.001
 20 to <30 y 1110 648 38.8 22.9 59.0 5.1 ± 0.5 Ref 1.9 ± 0.5 7.7 ± 0.9 19.3 ± 1.5
 30 to <40 y 1035 702 40.5 27.8 68.8 11.8 ± 0.7 <0.001 9.0 ± 0.7 16.5 ± 0.8 33.7 ± 2.1
 40 to <50 y 1027 792 38.5 29.1 75.7 16.4 ± 1.0 <0.001 13.2 ± 0.9 22.3 ± 1.2 44.6 ± 3.2
 50 to <60 y 856 690 37.9 30.5 80.5 18.0 ± 1.2 <0.001 14.7 ± 1.0 24.2 ± 1.4 47.6 ± 4.6
 ≥60 y 2191 1898 50.9 44.0 86.4 16.0 ± 0.5 <0.001 13.8 ± 0.5 21.1 ± 0.6 37.8 ± 1.3
Race/ethnicity <0.001
 Non-Hispanic white 3511 2726 150.8 114.2 75.7 16.0 ± 0.6 Ref 13.3 ± 0.4 21.9 ± 0.6 42.0 ± 2.3
 Non-Hispanic black 1186 758 23.4 14.4 61.4 7.3 ± 0.5 <0.001 5.3 ± 0.6 11.3 ± 0.8 22.4 ± 1.3
 Hispanic or other race 1522 1246 32.4 25.8 79.8 9.3 ± 0.4 <0.001 7.1 ± 0.4 13.0 ± 0.6 27.6 ± 1.5
Educational level 0.51
 High school diploma or less 3105 2425 87.8 66.2 75.4 13.8 ± 0.6 Ref 10.9 ± 0.4 19.0 ± 0.7 38.6 ± 2.1
 More than high school diploma 3109 2302 118.7 88.1 74.2 14.3 ± 0.5 0.48 11.6 ± 0.5 20.2 ± 0.7 39.2 ± 2.1
Annual household income 0.92
 <$55,000 3828 2940 110.5 82.6 74.8 13.5 ± 0.6 Ref 10.9 ± 0.5 18.9 ± 0.8 37.7 ± 2.2
 ≥$55,000 2083 1554 86.0 64.2 74.6 14.7 ± 0.5 0.20 11.8 ± 0.4 20.4 ± 0.6 40.2 ± 2.0
Smoking status <0.001
 Never 3215 2231 103.5 69.6 67.2 10.6 ± 0.2 Ref 8.4 ± 0.3 15.2 ± 0.5 29.4 ± 1.3
 Former 1690 1437 53.5 45.1 84.4 15.6 ± 1.7 <0.001 13.4 ± 0.7 21.3 ± 0.8 38.3 ± 1.6
 Current 1311 1059 49.6 39.6 80.0 18.6 ± 1.0 <0.001 15.0 ± 0.7 25.7 ± 1.1 51.8 ± 4.0
Alcohol intake <0.001
 Nondrinker 2159 1541 58.6 39.3 67.1 13.9 ± 0.8 Ref 10.9 ± 0.6 18.7 ± 0.9 39.6 ± 2.9
 <14 g ethanol/d 3106 2431 110.8 85.5 77.2 13.7 ± 0.4 0.79 11.1 ± 0.4 19.2 ± 0.5 37.4 ± 1.6
 ≥14 g ethanol/d 666 541 27.1 22.2 82.0 17.0 ± 1.3 0.04 14.6 ± 1.2 24.0 ± 1.5 43.5 ± 4.1
General health condition 0.46
 Excellent or very good 2523 1853 94.6 70.0 74.0 14.8 ± 0.5 Ref 12.2 ± 0.5 20.6 ± 0.6 39.7 ± 2.2
 Good 2223 1722 71.7 53.8 75.0 13.3 ± 0.6 0.05 10.6 ± 0.5 18.7 ± 0.7 37.1 ± 1.8
 Fair or poor 1024 955 30.7 23.8 77.5 14.4 ± 1.0 0.66 11.2 ± 0.8 19.5 ± 1.2 41.2 ± 3.4
1

fl oz, fluid ounces; Ref, reference.

2

Usual intake was determined by using the National Cancer Institute method with self-reported frequency of coffee intake, age, sex, race-ethnicity, educational level, annual household income, smoking status, alcohol drinking status, and general health condition as covariates with 2 d of dietary recall from NHANES 2003–2004 and 2005–2006. 1 fl oz = 29.6 mL.

3

May not total 6219 due to missing data.

4

Coffee drinkers are defined as those who reported ever consuming coffee in the previous 12 mo on the FFQ or reported coffee intake on one or more 24-h dietary recalls. Numbers may not total 4730 due to missing data.

5

May not total 206.6 million due to missing data.

6

May not total 154.4 million due to missing data.

7

Derived by using chi-square test of independence for percentage of coffee drinkers (yes or no) across categories of a given characteristic.

8

Derived by using unpaired t test between categories of a given characteristic and reference group for that characteristic.

The estimated proportion of daily coffee drinkers was 49.0%, representing 101.1 million US adults (Table 2). The prevalence of daily coffee drinking differed by sex (P = 0.03), but otherwise patterns were similar to those for overall coffee drinking.

TABLE 2.

Prevalence of daily coffee drinking among adults, aged ≥20 y, in the United States: NHANES 2003–2006

Sample size
Weighted to US adult population1
Characteristic Daily coffee drinkers,3 n Daily coffee drinkers,4 n (millions) Daily coffee drinkers, % P2
Overall 3015 101.1 49.0
Sex 0.03
 Female 1520 53.2 47.3
 Male 1495 47.9 50.9
Age <0.001
 20 to <30 y 213 8.0 20.8
 30 to <40 y 341 15.5 38.4
 40 to <50 y 501 19.8 51.5
 50 to <60 y 484 22.5 59.3
 ≥60 y 1476 35.2 69.2
Race/ethnicity <0.001
 Non-Hispanic black 339 6.0 25.8
 Hispanic or other race 703 13.8 42.7
 Non-Hispanic white 1973 81.2 53.9
Educational level 0.30
 High school diploma or less 1582 44.1 50.2
 More than high school diploma 1431 57.0 48.0
Annual household income 0.69
 <$55,000 1892 53.7 48.6
 ≥$55,000 982 42.5 49.5
Smoking status < 0.001
 Never 1216 39.4 38.1
 Former 1058 33.6 62.9
 Current 740 28.0 56.5
Alcohol intake 0.01
 Nondrinker 1015 26.1 44.6
 <14 g ethanol/d 1489 54.8 49.5
 ≥14 g ethanol/d 384 15.6 57.7
General health condition 0.16
 Excellent or very good 1192 47.0 49.6
 Good 1061 33.7 47.0
 Fair or poor 646 16.3 53.0
1

Daily coffee drinkers are defined as those who reported consuming coffee ≥1 time/d in the previous 12 mo on the FFQ.

2

Derived by using chi-square test of independence for characteristic by daily coffee consumption (yes or no).

3

May not total 3015 due to missing data.

4

May not total 101.1 million due to missing data.

Usual coffee intake.

On average, the usual coffee intake among coffee drinkers in the United States is 14.1 ± 0.5 fluid ounces (fl oz)/d or ∼417 mL/d (1 fl oz = 29.6 mL) (Table 1). Approximately 63%, 35%, and 9% of coffee drinkers consumed ≥8, ≥16, and ≥32 fl oz/d, respectively (data not shown in Table 1). Among coffee drinkers, the 50th, 75th, and 95th percentiles of usual intakes were 11.4 ± 0.4, 19.7 ± 0.6, and 39.0 ± 1.8 fl oz/d (337 ± 9, 583 ± 18, and 1154 ± 53.3 mL/d), respectively (Table 1). Approximately 83% of US adult coffee drinkers consumed less than three 8-fl-oz cups of coffee/d and 95% consumed <5 cups; therefore, 12% of coffee drinkers consumed in the moderate, 3–5 cups/d, range (data not shown in Table 1), assuming 8 fl oz (237 mL) represents 1 standard US cup.

Patterns observed for the prevalence of coffee drinking extended to our estimates of daily consumption among coffee drinkers. No considerable differences in the distribution of usual intakes were observed by educational attainment, income, or self-reported general health condition (Table 1); however, on average, men drank significantly more than women (P < 0.001). For example, among coffee drinkers, 40% and 11% of men but only 29% and 6% of women consumed ≥16 and ≥32 fl oz/d, respectively (data not shown in Table 1). Usual coffee intakes also varied by age. For example, coffee drinkers aged 20–30 y [5.1 ± 0.5 fl oz/d (151 ± 15 mL/d)] had a significantly lower mean usual intake than those aged 50–60 y [18.0 ± 1.2 fl oz/d (533 ± 36 mL/d); P < 0.001]. The distribution of usual coffee consumption also varied by race/ethnicity, with significantly higher intakes among non-Hispanic whites [16.0 ± 0.6 fl oz/d (474 ± 18 mL/d)] than among non-Hispanic blacks [7.3 ± 0.5 fl oz/d (216 ± 15 mL/d); P < 0.001] and Hispanics or other races [9.3 ± 0.4 fl oz/d (276 ± 12 mL/d); P < 0.001]. Finally, the distribution of usual coffee intake differed by smoking and alcohol drinking status. Coffee drinkers who were never smokers had lower usual coffee intakes than former (P < 0.001) or current (P < 0.001) smokers. Those who did not consume alcohol had usual intakes similar to those who consumed alcohol infrequently (i.e., <14 g ethanol/d; P = 0.79) but lower usual intakes than frequent alcohol drinkers (i.e., ≥14 g ethanol/d; P = 0.04).

Acute compared with usual coffee intakes.

We compared the prevalence and intake amount as estimated by using 1 d of recall (i.e., acute intakes) with usual intakes as estimated by the NCI method. The population mean acute intake was 11.6 ± 0.5 fl oz/d (343 ± 15 mL/d; Supplemental Table 1), which, as expected, was similar to the estimate of 10.5 ± 0.3 fl oz/d (311 ± 9 mL/d) obtained by using the NCI method to integrate all available dietary data (data not shown in table). Among coffee drinkers, the median usual intake amount was also similar to the median acute intake; however, larger differences in estimates were observed at the tail-end of the distribution: the estimated 95th percentile of acute intake was >20% larger than the corresponding percentile of usual intake. In addition, the prevalence of coffee consumption was substantially underestimated by using only the first day of dietary recall (51.8%; data not shown in table) compared with the use of both days of recall plus an FFQ (74.7%; Table 1).

Trends in coffee intake.

Estimates of population mean coffee intakes remained consistent over the 10-y period (2003–2012) examined (P-trend = 0.09). We observed no significant differences in trends in population mean intakes between adults across categories for age (P-heterogeneity = 0.10), sex (P-heterogeneity = 0.30), or race/ethnicity (P-heterogeneity = 0.79) (Table 3).

TABLE 3.

Adjusted mean coffee intake among US adults aged ≥20 y: NHANES 2003–20121

Adjusted mean coffee intake, fluid ounces/d
NHANES survey cycle
Subgroup Overall (2003–2012) 2003–2004 2005–2006 2007–2008 2009–2010 2011–2012 P
Overall 11.4 ± 0.3 11.8 ± 0.6 11.8 ± 0.4 11.1 ± 0.5 11.6 ± 0.5 10.8 ± 0.4 0.092
Sex 0.303
 Female 10.0 ± 0.2 10.1 ± 0.4 10.2 ± 0.5 9.8 ± 0.5 10.2 ± 0.4 9.6 ± 0.4
 Male 12.9 ± 0.4 13.7 ± 0.9 13.6 ± 0.5 12.4 ± 0.7 13.0 ± 0.8 12.1 ± 0.8
Age 0.103
 20 to <30 y 4.8 ± 0.3 4.5 ± 0.5 4.0 ± 0.6 4.9 ± 0.7 5.8 ± 0.6 4.7 ± 0.7
 30 to <40 y 9.5 ± 0.4 10.0 ± 0.7 10.0 ± 0.7 8.7 ± 0.9 9.9 ± 1.0 9.1 ± 0.5
 40 to <50 y 13.4 ± 0.5 14.9 ± 1.3 14.5 ± 0.9 12.5 ± 0.7 13.1 ± 0.9 12.0 ± 1.1
 50 to <60 y 15.0 ± 0.6 15.2 ± 1.4 16.6 ± 1.2 15.1 ± 1.6 15.6 ± 0.8 13.0 ± 0.6
 ≥60 y 13.6 ± 0.4 13.9 ± 0.6 13.6 ± 0.6 13.5 ± 0.9 13.0 ± 0.5 14.1 ± 1.0
Race/ethnicity 0.793
 Non-Hispanic black 4.9 ± 0.2 5.3 ± 0.5 5.3 ± 0.5 4.4 ± 0.4 4.6 ± 0.3 4.8 ± 0.4
 Hispanic or other race 8.5 ± 0.3 8.9 ± 0.5 9.8 ± 0.5 8.0 ± 0.5 7.8 ± 0.5 8.3 ± 0.5
 Non-Hispanic white 13.2 ± 0.3 13.6 ± 0.6 13.5 ± 0.5 12.9 ± 0.6 13.7 ± 0.6 12.4 ± 0.5
1

n = 24,950. Adjusted population mean coffee intakes were estimated by using predicted marginal means ± SEs obtained from weighted regression models that predict day 1 dietary recall data from the main effects for sex, age group, and race/ethnicity and interactions between survey cycle and each of the main effects. 1 fluid ounce = 29.6 mL.

2

P-trend estimated with the Wald F test for NHANES survey cycle (continuous) for the population overall.

3

P-heterogeneity for trends estimated with the Wald F test for survey year (continuous) × subgroup of interest for each subgroup.

Discussion

On the basis of our analysis of NHANES data collected during 2003–2006, we estimated that >100 million US adults (49.0%) drank coffee daily and >154 million adults (74.4%) drank coffee during this time period. Given that our estimates of population mean coffee consumption were stable from 2003 through 2012, we conclude that our prevalence estimates based on 2003–2006 data are close to the current prevalence of US coffee drinking. Similarly, a 2012 report prepared by the Food and Drug Administration showed that US coffee consumption was nearly constant from 2006 through 2008 (33). Our study shows that coffee drinking is widespread but varies across categories of age, race/ethnicity, smoking, and alcohol intake, with younger adults, non-Hispanic blacks, never smokers, and nondrinkers of alcohol being less likely to drink coffee than their counterparts. These observations are important to consider in studies of coffee drinking and human health because each of these variables are predictors of numerous health-related outcomes. Furthermore, among coffee drinkers, the usual amount of coffee consumption varies by subgroup. On average, men, older adults (i.e., age groups ≥30 y compared with those 20 to <30 y), and non-Hispanic whites consume more coffee than their counterparts. In addition, current smokers consume more coffee, on average, than either former or never smokers; this observation was expected because caffeine and nicotine share a common metabolic pathway, cytochrome P450 1A2 (CYP1A2), the activity of which is upregulated by both exposures (34).

Previous prevalence estimates of coffee drinking in the United States are restricted to industry reports and to cohorts that include mostly older, non-Hispanic whites with higher-than-average educational attainment. For example, the National Coffee Association collected data via a random telephone survey in January and February 2009 and found that 77% of US adults aged ≥18 y drank coffee. The National Coffee Association estimated daily coffee consumption by regular coffee drinkers to be 24.0–28.8 fl oz (33, 35). In contrast, our study takes advantage of unique data that are part of the nationally representative NHANES and uses validated dietary assessment tools and statistical methods to estimate usual coffee intakes in the United States (28).

A limitation of all self-report dietary assessment tools is that they are prone to measurement error (as are all measurements, whether they are reports from questionnaires or biological measurements), and when using intake data from dietary recalls it is important to distinguish between 2 sources of error: within-person (including day-to-day) variability and systematic bias. The NCI method adjusts for within-person variability under the assumption that dietary recalls provide an unbiased measure of usual intake. A previous validation study measuring energy and protein with recovery biomarkers and dietary recalls suggested that this assumption may not hold (36), but because biomarkers specific to coffee consumption are not available, we do not know how much systematic bias remains uncorrected in our analysis. However, the aforementioned validation study and others (37, 38) found that within-person variability tends to be a large component of measurement error for recall-based assessments of several dietary components. In addition, it is plausible that coffee intake is captured with relatively little measurement error by self-report given that it is a singular dietary component (instead of coming from a wide range of sources) and seems to be a daily habit for a majority of coffee drinkers. The primary use of the FFQ in our analysis was to distinguish never coffee drinkers and daily coffee drinkers from episodic coffee drinkers; the recalls were used as the reference instrument for actual consumption frequency and amount. As noted, there were a few individuals identified as never consumers by the FFQ that reported consumption on recalls, suggesting some degree of misclassification. Although an extension to the NCI method allows for formally modeling never consumers by assuming an error-prone FFQ, the software is not readily available; and Kipnis et al. (26) pointed out that the modeling may not be stable when only 2 recalls are available (as in our case).

Although we found that a majority of coffee drinkers were daily coffee drinkers, a comparison of usual coffee intakes to acute coffee intakes suggests that a single day of dietary recall markedly overestimated the proportion of nondrinkers. The misclassification of episodic coffee drinkers as nondrinkers could potentially attenuate associations in epidemiologic studies. In this analysis, acute coffee intake also overestimated usual coffee intake, especially toward the higher end of the distribution. However, acute intake patterns by demographic, lifestyle, and other health-related characteristics appeared similar to usual intake patterns. Our results for coffee intake by sex, age, and race/ethnicity reflect those that were generated by the USDA with the use of the first day of dietary intake collected during NHANES 2007–2008 (39). Thus, the use of a single dietary recall for estimating the intakes of habitually consumed food components, such as coffee, may be justified in certain analyses. However, future studies that incorporate multiple 24-h recalls and FFQ data should be used in studies of health outcomes when possible.

In this study we did not estimate usual intakes of caffeinated and decaffeinated coffee, because nationally representative estimates of caffeine consumption among US adults have previously been published (40). Although caffeine is an important bioactive compound contained in coffee, epidemiologic studies have observed associations of both caffeinated and decaffeinated coffee drinking with total and cause-specific mortality (41, 42) as well as with incidence of diabetes (8) and cancer (16, 18, 43), suggesting that compounds in coffee, aside from caffeine, may affect human health.

We found that the prevalence and usual amount of coffee consumed was lower among younger individuals, but we also found that population mean coffee consumption did not change over time among age subgroups, suggesting an increase in coffee drinking with age rather than a birth-cohort effect. NHANES is, however, a cross-sectional study and therefore cannot be used to study individual-level changes in coffee drinking over time. Future longitudinal studies with repeated measures of coffee consumption over the lifetime are needed to examine changes in coffee consumption as individuals age and to investigate possible differences by birth cohort. Our results also showed that non-Hispanic black Americans are less likely to drink coffee than their non-Hispanic white counterparts. Although results from the US Multiethnic Cohort suggest that the associations of coffee with incidence of liver cancer and death from liver disease (44) are similar regardless of race/ethnicity, many of the observed associations between coffee and health have not been studied in racially diverse cohorts.

In summary, a large majority of US adults are coffee drinkers. Yet, the prevalence and usual intakes of coffee vary by demographic and lifestyle factors that are associated with mortality and morbidity. Furthermore, within-person variability in coffee consumption should be accounted for in epidemiologic studies whenever possible.

Acknowledgments

EL, NDF, RS, and BIG designed the research and had primary responsibility for the final content; EL conducted the research and wrote the manuscript; KWD, EV, and QX provided essential materials; and EL, KWD, and BIG analyzed the data or performed the statistical analysis. All authors read and approved the final manuscript.

Footnotes

6

Abbreviations used: CYP1A2, cytochrome P450 1A2; fl oz, fluid ounces; MEC, mobile examination center; NCI, National Cancer Institute.

References

  • 1.Ukers WH. All about coffee. New York: The Tea & Coffee Trade Journal Co.; 1935. [Google Scholar]
  • 2.Foreign Agriculture Service. 2015/2016 Forecast overview. Coffee: world markets and trade. Washington (DC): USDA; 2015. [Google Scholar]
  • 3.Jick H, Miettinen OS, Neff RK, Shapiro S, Heinonen OP, Slone D. Coffee and myocardial infarction. N Engl J Med 1973;289:63–7. [DOI] [PubMed] [Google Scholar]
  • 4.Wu JN, Ho SC, Zhou C, Ling WH, Chen WQ, Wang CL, Chen YM. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 2009;137:216–25. [DOI] [PubMed] [Google Scholar]
  • 5.Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014;129:643–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Malerba S, Turati F, Galeone C, Pelucchi C, Verga F, La Vecchia C, Tavani A. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 2013;28:527–39. [DOI] [PubMed] [Google Scholar]
  • 7.Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol 2014;180:763–75. [DOI] [PubMed] [Google Scholar]
  • 8.Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009;169:2053–63. [DOI] [PubMed] [Google Scholar]
  • 9.Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, Hollenbeck AR, Blair A, Chen H. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol 2012;175:1200–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang L, Shen X, Wu Y, Zhang D. Coffee and caffeine consumption and depression: a meta-analysis of observational studies. Aust N Z J Psychiatry 2016;50:228–42. [DOI] [PubMed] [Google Scholar]
  • 11.Grosso G, Micek A, Pajak A, Castellano S, Galvano F. Coffee, tea, caffeine and risk of depression: a systematic review and dose-response meta-analysis of observational studies. Mol Nutr Food Res 2016;60:223–34. [DOI] [PubMed] [Google Scholar]
  • 12.Sang LX, Chang B, Li XH, Jiang M. Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol 2013;13:34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lai GY, Weinstein SJ, Albanes D, Taylor PR, McGlynn KA, Virtamo J, Sinha R, Freedman ND. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer 2013;109:1344–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Galeone C, Turati F, La Vecchia C, Tavani A. Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 2010;21:1949–59. [DOI] [PubMed] [Google Scholar]
  • 15.Je Y, Liu W, Giovannucci E. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 2009;124:1662–8. [DOI] [PubMed] [Google Scholar]
  • 16.Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y, Freedman ND. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 2012;96:374–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Je Y, Giovannucci E. Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J Cancer 2012;131:1700–10. [DOI] [PubMed] [Google Scholar]
  • 18.Gunter MJ, Schaub JA, Xue X, Freedman ND, Gaudet MM, Rohan TE, Hollenbeck AR, Sinha R. A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer 2012;131:E530–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yew YW, Lai YC, Schwartz RA. Coffee consumption and melanoma: a systematic review and meta-analysis of observational studies. Am J Clin Dermatol 2016;17:113–23. [DOI] [PubMed] [Google Scholar]
  • 20.Loftfield E, Freedman ND, Graubard BI, Hollenbeck AR, Shebl FM, Mayne ST, Sinha R. Coffee drinking and cutaneous melanoma risk in the NIH-AARP Diet and Health Study. J Natl Cancer Inst 2015;107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wu S, Han J, Song F, Cho E, Gao X, Hunter DJ, Qureshi AA. Caffeine intake, coffee consumption, and risk of cutaneous malignant melanoma. Epidemiology 2015;26:898–908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Song F, Qureshi AA, Han J. Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res 2012;72:3282–9. [DOI] [PubMed] [Google Scholar]
  • 23.Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study. Eur J Cancer Prev 2014;23:296–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Dietary Guidelines Advisory Committee. Scientific report of the 2015 Dietary Guidelines Advisory Committee. Washington (DC): USDA, US Department of Health and Human Services; 2015. [Google Scholar]
  • 25.Subar AF, Dodd KW, Guenther PM, Kipnis V, Midthune D, McDowell M, Tooze JA, Freedman LS, Krebs-Smith SM. The Food Propensity Questionnaire: concept, development, and validation for use as a covariate in a model to estimate usual food intake. J Am Diet Assoc 2006;106:1556–63. [DOI] [PubMed] [Google Scholar]
  • 26.Kipnis V, Midthune D, Buckman DW, Dodd KW, Guenther PM, Krebs-Smith SM, Subar AF, Tooze JA, Carroll RJ, Freedman LS. Modeling data with excess zeros and measurement error: application to evaluating relationships between episodically consumed foods and health outcomes. Biometrics 2009;65:1003–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Subar AF, Freedman LS, Tooze JA, Kirkpatrick SI, Boushey C, Neuhouser ML, Thompson FE, Potischman N, Guenther PM, Tarasuk V, et al. Addressing current criticism regarding the value of self-report dietary data. J Nutr 2015;145:2639–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tooze JA, Kipnis V, Buckman DW, Carroll RJ, Freedman LS, Guenther PM, Krebs-Smith SM, Subar AF, Dodd KW. A mixed-effects model approach for estimating the distribution of usual intake of nutrients: the NCI method. Stat Med 2010;29:2857–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National Health and Nutrition Examination Survey: plan and operations, 1999–2010. Hyattsville (MD): National Center for Health Statistics; 2013. [PubMed] [Google Scholar]
  • 30.Korn EL, Graubard BI. Analysis of health surveys. New York: Wiley; 1999. [Google Scholar]
  • 31.National Cancer Institute. Usual dietary intakes: SAS macros for analysis of a single dietary component [cited 2015 Oct 2]. Available from: http://epi.grants.cancer.gov/diet/usualintakes/macros_single.html.
  • 32.Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999;55:652–9. [DOI] [PubMed] [Google Scholar]
  • 33.Somogyi LP. Caffeine intake by the U.S. population. Silver Spring (MD): Food and Drug Administration; 2010. [Google Scholar]
  • 34.Rodenburg EM, Eijgelsheim M, Geleijnse JM, Amin N, van Duijn CM, Hofman A, Uitterlinden AG, Stricker BH, Visser LE. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking. Am J Clin Nutr 2012;96:182–7. [DOI] [PubMed] [Google Scholar]
  • 35.National Coffee Association, editor. National coffee drinking trends. New York: National Coffee Association; 2009. [Google Scholar]
  • 36.Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S, Sharbaugh CO, Trabulsi J, Runswick S, Ballard-Barbash R, et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003;158:1–13. [DOI] [PubMed] [Google Scholar]
  • 37.Freedman LS, Commins JM, Moler JE, Arab L, Baer DJ, Kipnis V, Midthune D, Moshfegh AJ, Neuhouser ML, Prentice RL, et al. Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol 2014;180:172–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Freedman LS, Commins JM, Moler JE, Willett W, Tinker LF, Subar AF, Spiegelman D, Rhodes D, Potischman N, Neuhouser ML, et al. Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for potassium and sodium intake. Am J Epidemiol 2015;181:473–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.LaComb RP, Sebastian RS, Wilkinson Enns C, Goldman JD. Beverage choices of U.S. adults: What We Eat In America, NHANES 2007–2008. Beltsville (MD): Food Surveys Research Group, US Department of Agriculture; 2011. (Dietary Data Brief 6.) [Google Scholar]
  • 40.Fulgoni VL III, Keast DR, Lieberman HR. Trends in intake and sources of caffeine in the diets of US adults: 2001–2010. Am J Clin Nutr 2015;101:1081–7. [DOI] [PubMed] [Google Scholar]
  • 41.Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012;366:1891–904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Loftfield E, Freedman ND, Graubard BI, Guertin KA, Black A, Huang WY, Shebl FM, Mayne ST, Sinha R. Association of coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am J Epidemiol 2015;182:1010–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Je Y, Hankinson SE, Tworoger SS, De Vivo I, Giovannucci E. A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol Biomarkers Prev 2011;20:2487–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology 2015;148:118–25; quiz: e15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES